US FDA’s Trump Transition Relatively Smooth, Except For Diversity, Equity Work

 
• By Sarah Karlin-Smith
  
headshots of diverse people pasted side by side
The FDA's efforts to better understand medical product safety and efficacy in different populations could be at risk during the Trump Administration. (Shutterstock)

More from Diversity & Inclusion

More from R&D